Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort Journal Article


Authors: Yerram, P.; Reiss, S. N.; Modelevsky, L.; Schaff, L.; Reiner, A. S.; Panageas, K. S.; Grommes, C.
Article Title: Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort
Journal Title: Annals of Lymphoma
Volume: 7
ISSN: 2616-2695
Publisher: AME Publishing Company  
Date Published: 2023-02-23
Start Page: 1
PROVIDER: manual
PMCID: PMC10100595
PUBMED: 37067886
DOI: 10.21037/aol-22-19
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record and PDF. Corresponding MSK author is Christian Grommes.
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anne S Reiner
    250 Reiner
  2. Christian Grommes
    153 Grommes
  3. Katherine S Panageas
    516 Panageas
  4. Samantha Nicole Reiss
    14 Reiss
  5. Lauren Rhea Schaff
    59 Schaff
  6. Prakirthi Yerram
    9 Yerram